ROYALTY PHARMA PLC- CL A (RPRX) Stock Earnings & Estimates
USA - NASDAQ:RPRX - GB00BMVP7Y09 - Common Stock
36.41 USD
-0.85 (-2.28%)
36.41 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.237B -2.28% | 2.355B 5.25% | 2.264B -3.86% | 3.058B 35.10% | 3.123B 2.13% | 3.338B 6.88% | 4.255B 27.47% | 4.544B 6.79% | 4.877B 7.33% | 5.024B 3.01% | 5.174B 2.99% | |
| EBITDA YoY % growth | N/A 31.88% | N/A 7.26% | N/A -6.92% | 2.9B 11.62% | 3.134B 8.07% | 3.386B 8.04% | 3.891B 14.91% | 4.29B 10.25% | 4.673B 8.93% | 4.817B 3.08% | 5.111B 6.10% | |
| EBIT YoY % growth | 922.9M -35.49% | 1.492B 61.68% | 1.292B -13.38% | 2.753B 113.01% | 2.958B 7.45% | 2.884B -2.50% | 2.35B -18.52% | 2.514B 6.98% | 2.642B 5.09% | 2.844B 7.65% | 2.924B 2.81% | |
| Operating Margin | 41.25% | 63.37% | 57.10% | 90.03% | 94.72% | 86.40% | 55.23% | 55.33% | 54.17% | 56.61% | 56.51% | |
| EPS YoY % growth | 3.67 64.57% | 4.38 19.35% | 4.10 -6.39% | 4.58 11.62% | 5.07 10.69% | 5.71 12.82% | 7.19 25.83% | 7.72 7.38% | 8.35 8.19% | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.07 5.48% | 1.30 12.92% | 1.39 114.20% | 1.44 26.16% | 1.59 49.35% | 1.96 50.80% |
| Revenue Q2Q % growth | 754.04M 33.46% | 769.02M 29.46% | 849.66M 1.27% | 774.18M 6.49% | 965.94M 28.10% | 1.01B 31.34% |
| EBITDA Q2Q % growth | 709.73M 7.82% | 667.19M 1.38% | 804.78M 12.16% | 733.38M 16.39% | 900.66M 26.90% | 965.94M 44.78% |
| EBIT Q2Q % growth | 685.45M -6.75% | 670.26M 85.40% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.14 18.75% | 1.11 | 0.03 | 3.01% |
| Q1 2025 Q2Q % growth | 0.65 -33.67% | 1.62 | -0.97 | -59.90% |
| Q4 2024 Q2Q % growth | 1.15 | 1.08 | 0.07 | 6.88% |
| Q3 2024 Q2Q % growth | 1.01 27.85% | 0.95 | 0.06 | 6.65% |
| Q2 2024 Q2Q % growth | 0.96 14.29% | 0.98 | -0.02 | -2.47% |
| Q1 2024 Q2Q % growth | 0.98 -38.75% | 1.00 | -0.02 | -2.16% |
| Q4 2023 Q2Q % growth | 1.15 -26.28% | 1.03 | 0.12 | 11.63% |
| Q3 2023 Q2Q % growth | 0.79 9.72% | 0.77 | 0.02 | 2.45% |
| Q2 2023 Q2Q % growth | 0.84 6.33% | 0.82 | 0.02 | 1.92% |
| Q1 2023 Q2Q % growth | 1.60 166.67% | 1.30 | 0.30 | 23.19% |
| Q4 2022 Q2Q % growth | 1.56 95.00% | 1.50 | 0.06 | 3.86% |
| Q3 2022 Q2Q % growth | 0.72 323.53% | 0.73 | -0.01 | -1.45% |
| Q2 2022 Q2Q % growth | 0.79 -26.85% | 0.80 | -0.01 | -0.86% |
| Q1 2022 Q2Q % growth | 0.60 233.33% | 0.75 | -0.15 | -19.60% |
| Q4 2021 Q2Q % growth | 0.80 185.71% | 0.79 | 0.01 | 1.20% |
| Q3 2021 Q2Q % growth | 0.17 -64.58% | 0.71 | -0.54 | -75.92% |
| Q2 2021 Q2Q % growth | 1.08 47.95% | 0.71 | 0.37 | 52.35% |
| Q1 2021 Q2Q % growth | 0.18 | 0.66 | -0.48 | -72.85% |
| Q4 2020 Q2Q % growth | 0.28 | 0.71 | -0.43 | -60.46% |
| Q3 2020 Q2Q % growth | 0.48 | 0.60 | -0.12 | -20.46% |
| Q2 2020 Q2Q % growth | 0.73 | 0.62 | 0.11 | 17.60% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 727M 19.57% | 697.73M | 29.27M | 4.20% |
| Q1 2025 Q2Q % growth | 839M 47.71% | 765.47M | 73.53M | 9.61% |
| Q4 2024 Q2Q % growth | 594M -0.34% | 692.47M | -98.47M | -14.22% |
| Q3 2024 Q2Q % growth | 565M 5.35% | 710.02M | -145.02M | -20.42% |
| Q2 2024 Q2Q % growth | 608M 13.01% | 641.1M | -33.1M | -5.16% |
| Q1 2024 Q2Q % growth | 568M -16.96% | 676.48M | -108.48M | -16.04% |
| Q4 2023 Q2Q % growth | 596M 5.36% | 705.48M | -109.48M | -15.52% |
| Q3 2023 Q2Q % growth | 536.313M -6.48% | 630.35M | -94.037M | -14.92% |
| Q2 2023 Q2Q % growth | 538M 0.37% | 547.32M | -9.32M | -1.70% |
| Q1 2023 Q2Q % growth | 684M 21.71% | 869.96M | -185.96M | -21.38% |
| Q4 2022 Q2Q % growth | 565.7M -1.74% | 970.32M | -404.62M | -41.70% |
| Q3 2022 Q2Q % growth | 573.5M -2.10% | 598.92M | -25.42M | -4.24% |
| Q2 2022 Q2Q % growth | 536M -3.42% | 553.02M | -17.02M | -3.08% |
| Q1 2022 Q2Q % growth | 562M -1.92% | 611.75M | -49.75M | -8.13% |
| Q4 2021 Q2Q % growth | 575.7M 0.63% | 567.42M | 8.28M | 1.46% |
| Q3 2021 Q2Q % growth | 585.8M 8.80% | 584.26M | 1.54M | 0.26% |
| Q2 2021 Q2Q % growth | 555M 8.63% | 528.25M | 26.75M | 5.06% |
| Q1 2021 Q2Q % growth | 573M 14.39% | 519.89M | 53.11M | 10.22% |
| Q4 2020 Q2Q % growth | 572.1M 25.05% | 490.33M | 81.77M | 16.68% |
| Q3 2020 Q2Q % growth | 538.4M 15.96% | 462.23M | 76.17M | 16.48% |
| Q2 2020 Q2Q % growth | 510.9M 11.65% | 478.34M | 32.56M | 6.81% |
| Q1 2020 Q2Q % growth | 500.9M 15.18% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.16% | -2.73% | -0.33% | 4.74% |
| Revenue | 0.7% | -0.09% | 0.07% | 4.44% |